
FDA Approves Imbruvica for MCL, Second Breakthrough Therapy Drug to Reach Approval
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000440863.95411.3c
Subject(s) - drug , medicine , drug approval , pharmacology